[go: up one dir, main page]

DK518683D0 - Fremgangsmade til fremstilling af 4"epi-9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin a eller farmaceutisk acceptable syreadditionssalte deraf og mellemprodukter ved fremgangsmaden - Google Patents

Fremgangsmade til fremstilling af 4"epi-9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin a eller farmaceutisk acceptable syreadditionssalte deraf og mellemprodukter ved fremgangsmaden

Info

Publication number
DK518683D0
DK518683D0 DK5186/83A DK518683A DK518683D0 DK 518683 D0 DK518683 D0 DK 518683D0 DK 5186/83 A DK5186/83 A DK 5186/83A DK 518683 A DK518683 A DK 518683A DK 518683 D0 DK518683 D0 DK 518683D0
Authority
DK
Denmark
Prior art keywords
procedure
deoxo
epi
aza
intermediates
Prior art date
Application number
DK5186/83A
Other languages
English (en)
Other versions
DK159322C (da
DK518683A (da
DK159322B (da
Inventor
Gene Michael Bright
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK518683D0 publication Critical patent/DK518683D0/da
Publication of DK518683A publication Critical patent/DK518683A/da
Publication of DK159322B publication Critical patent/DK159322B/da
Application granted granted Critical
Publication of DK159322C publication Critical patent/DK159322C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Cosmetics (AREA)
DK518683A 1982-11-15 1983-11-14 Analogifremgangsmaade til fremstilling af 4ae-epi-9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin a eller farmaceutisk acceptable syreadditionssalte deraf og 4ae-epi-9-deoxy-9a-aza-9a-homoerythromycin a til anvendelse som udgangsmateriale ved fremgangsmaaden DK159322C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44197982A 1982-11-15 1982-11-15
US44197982 1982-11-15

Publications (4)

Publication Number Publication Date
DK518683D0 true DK518683D0 (da) 1983-11-14
DK518683A DK518683A (da) 1984-05-16
DK159322B DK159322B (da) 1990-10-01
DK159322C DK159322C (da) 1991-02-25

Family

ID=23755068

Family Applications (1)

Application Number Title Priority Date Filing Date
DK518683A DK159322C (da) 1982-11-15 1983-11-14 Analogifremgangsmaade til fremstilling af 4ae-epi-9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin a eller farmaceutisk acceptable syreadditionssalte deraf og 4ae-epi-9-deoxy-9a-aza-9a-homoerythromycin a til anvendelse som udgangsmateriale ved fremgangsmaaden

Country Status (26)

Country Link
EP (1) EP0109253B1 (da)
JP (1) JPS59104398A (da)
KR (1) KR850000968B1 (da)
AT (1) ATE30237T1 (da)
AU (1) AU544790B2 (da)
CA (1) CA1239639A (da)
CS (1) CS241069B2 (da)
DD (1) DD216017A5 (da)
DE (1) DE3374065D1 (da)
DK (1) DK159322C (da)
EG (1) EG16641A (da)
ES (2) ES8600327A1 (da)
FI (1) FI72980C (da)
GR (1) GR79425B (da)
GT (1) GT198304062A (da)
HU (1) HU193886B (da)
IE (1) IE56234B1 (da)
IL (1) IL70228A (da)
NO (1) NO160262C (da)
NZ (1) NZ206259A (da)
PH (2) PH19293A (da)
PL (2) PL143281B1 (da)
PT (1) PT77645B (da)
SU (1) SU1272996A3 (da)
YU (2) YU43198B (da)
ZA (1) ZA838460B (da)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR80277B (en) * 1983-09-06 1985-01-04 Pfizer Azahomoerythromycin b derivatives and intermediates therefor
US4465674A (en) * 1983-09-06 1984-08-14 Pfizer Inc. Azahomoerythromycin D derivative and intermediates therefor
MX12213A (es) * 1987-07-09 1993-05-01 Pfizer Metodo de preparacion de dihidrato de azitromicina cristalino
WO1989002271A1 (en) * 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents
JP2751385B2 (ja) * 1988-05-19 1998-05-18 大正製薬株式会社 エリスロマイシンａオキシム及びその塩の製造方法
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
YU149889A (en) * 1989-07-26 1991-02-28 Pliva Zagreb Process for preparing biologically active derivatives of tylozine
US5912331A (en) * 1991-03-15 1999-06-15 Merck & Co., Inc. Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
US5985844A (en) * 1992-03-26 1999-11-16 Merck & Co., Inc. Homoerythromycin A derivatives modified at the 4"-and 8A-positions
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
CA2064985A1 (en) * 1991-04-05 1992-10-06 Robert R. Wilkening 8a-aza-8a-homoertyhromycin cyclic lactams
CA2065222A1 (en) * 1991-04-09 1992-10-10 Robert R. Wilkening Process for the preparation of 8a-aza-8a-homoerythromycin cyclic iminoethers
US5189159A (en) * 1992-04-02 1993-02-23 Merck & Co., Inc. 8a-AZA-8a-homoerythromycin cyclic iminoethers
EP0508795A1 (en) * 1991-04-10 1992-10-14 Merck & Co. Inc. 8a-aza-8a-homoerythromycin cyclic iminoethers
CA2065218A1 (en) * 1991-04-11 1992-10-12 Robert R. Wilkening Process for the preparation of 9-deoxo-8a-aza-8a-homoerythromycin a and its 8a-alkyl derivatives
CA2068951A1 (en) * 1991-05-20 1992-11-21 Robert R. Wilkening Process for the preparation of 8a-aza-8a-homoerythromycin cyclic lactams
EP0549040A1 (en) * 1991-12-20 1993-06-30 Merck & Co. Inc. Methods of making 4" derivatives of 9-deoxo-8a-aza-8a-alkyl-8a-homoerythromycin A
US5215980A (en) * 1992-01-17 1993-06-01 Merck & Co., Inc. 10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof
US5210235A (en) * 1992-08-26 1993-05-11 Merck & Co., Inc. Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
US5332807A (en) * 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
PL179910B1 (pl) 1994-05-06 2000-11-30 Pfizer Postac dawkowania o kontrolowanym uwalnianiu zawierajaca azytromycyne PL PL PL PL PL PL PL PL
UA52607C2 (uk) * 1995-06-29 2003-01-15 Тексіс Байотекнолоджі Корпорейшн Похідні біфенілів, фармацевтична композиція на їх основі та спосіб інгібування (варіанти)
HRP960497B1 (en) * 1996-10-28 2003-08-31 Pliva Pharm & Chem Works 9-n-ethenyl derivatives of 9(s)-erythromycylamine
PT102006B (pt) * 1997-05-19 2000-06-30 Hovione Sociedade Quimica S A Novo processo de preparacao de azitromicina
TW546302B (en) * 1998-05-08 2003-08-11 Biochemie Sa Improvements in macrolide production
EP1437360A3 (en) * 1998-08-19 2005-04-06 Pfizer Products Inc. C11 Carbamates of macrolide antibacterials
US6043227A (en) * 1998-08-19 2000-03-28 Pfizer Inc. C11 carbamates of macrolide antibacterials
AU6748500A (en) * 1999-08-24 2001-03-19 Abbott Laboratories 9a-azalides with antibacterial activity
US6764996B1 (en) 1999-08-24 2004-07-20 Abbott Laboratories 9a-azalides with antibacterial activity
ATE388159T1 (de) * 2000-01-04 2008-03-15 Teva Pharma Verfahren zur herstellung von azithromycin- dihydrat
WO2002015842A2 (en) 2000-08-23 2002-02-28 Wockhardt Limited Process for preparation of anhydrous azithromycin
US6852262B2 (en) 2002-05-09 2005-02-08 The Gillette Company Insert molding razor cartridges
HRP20020991A2 (en) * 2002-12-12 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. N"-Substituted 9a-N-(N'-carbamoyl-Gamma-aminopropyl), 9a-N-(N'? -thiocarbamoyl-Gamma-aminopropyl), 9a-N-(N'-((Beta-cyanoethyl)-N'-carbamoyl-Gamma? -aminopropyl) and 9a-N-(N'-(Beta-cyanoethyl)-N'-thiocarbamoyl-Gamma? -aminopropyl) derivatives of 9-de
PL1691787T3 (pl) 2003-12-04 2008-11-28 Pfizer Prod Inc Sposób wytwarzania farmaceutycznych systemów wielocząstkowych
EP1689368B1 (en) 2003-12-04 2016-09-28 Bend Research, Inc Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
CA2547597A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
US6984403B2 (en) 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
RU2256665C1 (ru) * 2004-01-29 2005-07-20 Открытое акционерное общество Акционерное Курганское общество медицинских препаратов и изделий "Синтез" Способ получения оксима эритромицина

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI7910768A8 (en) * 1979-04-02 1996-06-30 Pliva Pharm & Chem Works Process for pripering 11-aza-4-0-cladinosyl-6-0-desosaminyl-15-ethyl- 7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl- oxacyclopentadecane-2-one and their derivatives
JPS5788193A (en) * 1980-11-21 1982-06-01 Pliva Pharm & Chem Works 11-aza-10-deoxo-10-dihydroerythromycin a, derivatives and manufacture
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4382085A (en) * 1982-03-01 1983-05-03 Pfizer Inc. 4"-Epi erythromycin A and derivatives thereof as useful antibacterial agents

Also Published As

Publication number Publication date
JPH0140038B2 (da) 1989-08-24
FI834163L (fi) 1984-05-16
DD216017A5 (de) 1984-11-28
ES527249A0 (es) 1985-10-01
YU43198B (en) 1989-04-30
AU544790B2 (en) 1985-06-13
ZA838460B (en) 1985-06-26
PL250350A1 (en) 1985-04-24
CA1239639A (en) 1988-07-26
DK159322C (da) 1991-02-25
ES8600327A1 (es) 1985-10-01
JPS59104398A (ja) 1984-06-16
EP0109253B1 (en) 1987-10-14
NZ206259A (en) 1986-08-08
DE3374065D1 (en) 1987-11-19
PL244557A1 (en) 1985-03-26
YU43425B (en) 1989-06-30
NO160262B (no) 1988-12-19
IL70228A (en) 1987-03-31
PT77645A (en) 1983-12-01
SU1272996A3 (ru) 1986-11-23
NO834146L (no) 1984-05-16
FI72980C (fi) 1987-08-10
ES543638A0 (es) 1986-01-16
YU197285A (en) 1986-08-31
GT198304062A (es) 1985-05-04
FI834163A0 (fi) 1983-11-14
ES8604257A1 (es) 1986-01-16
NO160262C (no) 1989-03-29
IL70228A0 (en) 1984-02-29
PL143281B1 (en) 1988-01-30
FI72980B (fi) 1987-04-30
EG16641A (en) 1990-08-30
YU224383A (en) 1986-04-30
HUT35273A (en) 1985-06-28
PL142601B1 (en) 1987-11-30
CS845583A2 (en) 1985-07-16
KR850000968B1 (ko) 1985-07-02
EP0109253A3 (en) 1984-09-12
CS241069B2 (en) 1986-03-13
DK518683A (da) 1984-05-16
ATE30237T1 (de) 1987-10-15
IE56234B1 (en) 1991-05-22
PT77645B (en) 1986-05-12
PH21560A (en) 1987-12-11
GR79425B (da) 1984-10-22
IE832652L (en) 1984-05-15
KR840006673A (ko) 1984-12-01
HU193886B (en) 1987-12-28
PH19293A (en) 1986-03-04
DK159322B (da) 1990-10-01
EP0109253A2 (en) 1984-05-23
AU2130983A (en) 1984-05-24

Similar Documents

Publication Publication Date Title
DK518683D0 (da) Fremgangsmade til fremstilling af 4"epi-9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin a eller farmaceutisk acceptable syreadditionssalte deraf og mellemprodukter ved fremgangsmaden
DK163181C (da) Analogifremgangsmaade til fremstilling af n,n'-di(arylalkylen)alkylendiaminer eller farmaceutisk acceptable salte deraf
EP0136830A3 (en) Azahomoerythromycin d derivative and intermediates therefor
DK159450C (da) 9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin b og farmaceutisk acceptable syreadditionssalte deraf samt 9-deoxo-9a-aza-9a-homoerythromycin b til anvendelse som mellemprodukt ved fremstilling deraf
GR78622B (da)
PT87563A (pt) Process for the preparation of vinylcephalosporins useful as medicaments
SE8206128L (sv) Farmaceutisk komposition for behandling av njurstenar framkallade genom infektion
FI872459A7 (fi) Farmaseuttinen valmiste bakteeri-infektioiden hoitoon.
JPS57108083A (en) 5-phenyltetrazole compound
DK0418990T3 (da) 13-brom- og 13,14-dibrom-ergoliner, deres fremstilling og anvendelse i lægemidler
DK573981A (da) Fremgangsmaade til fremstilling af cis-c-3",c4"-carbonatderivater af o-demethyl-oleandomycin og mellemprodukter herfor
FI853506L (fi) Nya antibioter, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska kompositioner.
JPS52113944A (en) N-halogenobenzul-n-alkyl-n-phenyl-(thio)-ureas, preparation of the sa me, and method of combatting plant infections by using the same

Legal Events

Date Code Title Description
PBP Patent lapsed